Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Targeting Antigens to CD180 but Not CD40 Programs Immature and Mature B Cell Subsets to Become Efficient APCs.

Roe K, Shu GL, Draves KE, Giordano D, Pepper M, Clark EA.

J Immunol. 2019 Sep 4. pii: ji1900549. doi: 10.4049/jimmunol.1900549. [Epub ahead of print]

PMID:
31484732
2.

Health in Place.

Roe KM.

Health Promot Pract. 2019 Sep;20(5):637-638. doi: 10.1177/1524839919866204. No abstract available.

PMID:
31465252
3.

Ceramide: a novel inducer for neural tube defects.

Ross MM, Piorczynski TB, Harvey J, Burnham TS, Francis M, Larsen MW, Roe K, Hansen JM, Stark MR.

Dev Dyn. 2019 Aug 7. doi: 10.1002/dvdy.93. [Epub ahead of print]

PMID:
31390103
4.

Comorbidity Characterization Among eMERGE Institutions: A Pilot Evaluation with the Johns Hopkins Adjusted Clinical Groups® System.

Taylor CO, Lemke KW, Richards TM, Roe KD, He T, Arruda-Olson A, Carrell D, Denny JC, Hripcsak G, Kiryluk K, Kullo I, Larson EB, Peissig P, Walton NA, Wei-Qi W, Ye Z, Chute CG, Weiner JP.

AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:145-152. eCollection 2019.

5.

Dendritic cell-associated MAVS is required to control West Nile virus replication and ensuing humoral immune responses.

Roe K, Giordano D, Young LB, Draves KE, Holder U, Suthar MS, Gale M Jr, Clark EA.

PLoS One. 2019 Jun 26;14(6):e0218928. doi: 10.1371/journal.pone.0218928. eCollection 2019.

6.

Summer Reading!

Roe K.

Health Promot Pract. 2019 Jul;20(4):473-475. doi: 10.1177/1524839919852962. No abstract available.

PMID:
31208234
7.

Stopping Untreatable Pathogen Infections Using Peptide Ligands to Sabotage Pathogenic Cell Surface Proteins.

Roe K.

Mol Biotechnol. 2019 Aug;61(8):602-609. doi: 10.1007/s12033-019-00189-z. Review.

PMID:
31161299
8.

Mitigating gender bias in student evaluations of teaching.

Peterson DAM, Biederman LA, Andersen D, Ditonto TM, Roe K.

PLoS One. 2019 May 15;14(5):e0216241. doi: 10.1371/journal.pone.0216241. eCollection 2019.

9.

A Message to the Graduates.

Roe KM.

Health Promot Pract. 2019 May;20(3):321-324. doi: 10.1177/1524839919843543. No abstract available.

PMID:
30977690
10.

The Fierce and Essential Hopefulness of Health Promotion Practice.

Roe KM.

Health Promot Pract. 2019 Jan;20(1):5-7. doi: 10.1177/1524839918817279. No abstract available.

PMID:
30791723
11.

Analysis of mitochondrial genomes resolves the phylogenetic position of Chinese freshwater mussels (Bivalvia, Unionidae).

Wu RW, Liu XJ, Wang S, Roe KJ, Ouyang S, Wu XP.

Zookeys. 2019 Jan 3;(812):23-46. doi: 10.3897/zookeys.812.29908. eCollection 2019.

12.

Pervasive iron limitation at subsurface chlorophyll maxima of the California Current.

Hogle SL, Dupont CL, Hopkinson BM, King AL, Buck KN, Roe KL, Stuart RK, Allen AE, Mann EL, Johnson ZI, Barbeau KA.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):13300-13305. doi: 10.1073/pnas.1813192115. Epub 2018 Dec 10.

13.

Studies and Stories for Health Promotion Practice.

Roe KM.

Health Promot Pract. 2018 Nov;19(6):801-802. doi: 10.1177/1524839918803941. No abstract available.

PMID:
30322311
14.

Enhanced climate instability in the North Atlantic and southern Europe during the Last Interglacial.

Tzedakis PC, Drysdale RN, Margari V, Skinner LC, Menviel L, Rhodes RH, Taschetto AS, Hodell DA, Crowhurst SJ, Hellstrom JC, Fallick AE, Grimalt JO, McManus JF, Martrat B, Mokeddem Z, Parrenin F, Regattieri E, Roe K, Zanchetta G.

Nat Commun. 2018 Oct 12;9(1):4235. doi: 10.1038/s41467-018-06683-3.

15.

Editor's Commentary.

Roe KM.

Health Promot Pract. 2018 Sep;19(5):641-642. doi: 10.1177/1524839918795152. No abstract available.

PMID:
30175662
16.

Testing the utility of DNA barcodes and a preliminary phylogenetic framework for Chinese freshwater mussels (Bivalvia: Unionidae) from the middle and lower Yangtze River.

Wu RW, Liu YT, Wang S, Liu XJ, Zanatta DT, Roe KJ, Song XL, An CT, Wu XP.

PLoS One. 2018 Aug 8;13(8):e0200956. doi: 10.1371/journal.pone.0200956. eCollection 2018.

17.

Correction for Kumar et al., "Inflammasome Adaptor Protein Apoptosis-Associated Speck-Like Protein Containing CARD (ASC) Is Critical for the Immune Response and Survival in West Nile Virus Encephalitis".

Kumar M, Roe K, Orillo B, Muruve DA, Nerurkar VR, Gale M Jr, Verma S.

J Virol. 2018 Jul 17;92(15). pii: e02176-17. doi: 10.1128/JVI.02176-17. Print 2018 Aug 1. No abstract available.

18.

What We Choose to Emphasize.

Roe KM.

Health Promot Pract. 2018 May;19(3):321-322. doi: 10.1177/1524839918770685. No abstract available.

PMID:
29708016
19.

Health Promotion for These Times.

Roe KM.

Health Promot Pract. 2018 Mar;19(2):165-166. doi: 10.1177/1524839918758699. No abstract available.

PMID:
29451030
20.

It Takes a Village: First Reflections From HPP's New Editor-in-Chief.

Roe KM.

Health Promot Pract. 2018 Jan;19(1):5-7. doi: 10.1177/1524839917744730. No abstract available.

PMID:
29291275
21.

Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization.

Giordano D, Draves KE, Young LB, Roe K, Bryan MA, Dresch C, Richner JM, Diamond MS, Gale M Jr, Clark EA.

PLoS Pathog. 2017 Nov 27;13(11):e1006743. doi: 10.1371/journal.ppat.1006743. eCollection 2017 Nov.

22.

Helen Stapely Ross, EdD, MPH (1921-2016).

Roe KM, Perales DP.

Health Educ Behav. 2017 Apr;44(2):340. doi: 10.1177/1090198117699511. No abstract available.

PMID:
28330387
23.

Nephrologists' likelihood of referring patients for kidney transplant based on hypothetical patient scenarios.

Tandon A, Wang M, Roe KC, Patel S, Ghahramani N.

Clin Kidney J. 2016 Aug;9(4):611-5. doi: 10.1093/ckj/sfw031. Epub 2016 May 17.

24.

Species-Level Variability in Extracellular Production Rates of Reactive Oxygen Species by Diatoms.

Schneider RJ, Roe KL, Hansel CM, Voelker BM.

Front Chem. 2016 Mar 30;4:5. doi: 10.3389/fchem.2016.00005. eCollection 2016.

25.

Incongruence between mtDNA and nuclear data in the freshwater mussel genus Cyprogenia (Bivalvia: Unionidae) and its impact on species delineation.

Chong JP, Harris JL, Roe KJ.

Ecol Evol. 2016 Mar 11;6(8):2439-52. doi: 10.1002/ece3.2071. eCollection 2016 Apr.

26.

Letter to the Editor: Primary Breast Cancer Decision-making Among Chinese American Women, Lee & Knobf (2015).

Roe K.

Nurs Res. 2016 Mar-Apr;65(2):91-2. doi: 10.1097/NNR.0000000000000142. No abstract available.

PMID:
26938354
27.
28.

Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.

Nelson J, Roe K, Orillo B, Shi PY, Verma S.

Antiviral Res. 2015 Oct;122:39-45. doi: 10.1016/j.antiviral.2015.07.008. Epub 2015 Jul 29.

29.

Trends in animal use at US research facilities.

Goodman J, Chandna A, Roe K.

J Med Ethics. 2015 Jul;41(7):567-9. doi: 10.1136/medethics-2014-102404. Epub 2015 Feb 25.

PMID:
25717142
30.

Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?

Roe K, Gibot S, Verma S.

Front Microbiol. 2014 Nov 26;5:627. doi: 10.3389/fmicb.2014.00627. eCollection 2014. Review.

31.

"Lead, follow, or get out of the way": Noreen Clark and commitments to practice.

Roe KM.

Health Educ Behav. 2014 Oct;41(5):552-3. doi: 10.1177/1090198114548480. No abstract available.

PMID:
25270181
32.

Uptake mechanisms for inorganic iron and ferric citrate in Trichodesmium erythraeum IMS101.

Roe KL, Barbeau KA.

Metallomics. 2014 Nov;6(11):2042-51. doi: 10.1039/c4mt00026a.

PMID:
25222699
33.
34.

Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts.

Kristian A, Nilsen LB, Røe K, Revheim ME, Engebråten O, Mælandsmo GM, Holm R, Malinen E, Seierstad T.

Nucl Med Mol Imaging. 2013 Sep;47(3):173-80. doi: 10.1007/s13139-013-0211-y. Epub 2013 Jun 21.

35.

Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus.

Kumar M, Roe K, Nerurkar PV, Orillo B, Thompson KS, Verma S, Nerurkar VR.

J Neuroinflammation. 2014 Apr 21;11:80. doi: 10.1186/1742-2094-11-80.

36.

Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.

Ree AH, Saelen MG, Kalanxhi E, Østensen IH, Schee K, Røe K, Abrahamsen TW, Dueland S, Flatmark K.

PLoS One. 2014 Feb 25;9(2):e89750. doi: 10.1371/journal.pone.0089750. eCollection 2014.

37.

Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer.

Ragnum HB, Røe K, Holm R, Vlatkovic L, Nesland JM, Aarnes EK, Ree AH, Flatmark K, Seierstad T, Lilleby W, Lyng H.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):753-60. doi: 10.1016/j.ijrobp.2013.07.023. Epub 2013 Sep 10.

PMID:
24035332
38.

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma.

Tahiri A, Røe K, Ree AH, de Wijn R, Risberg K, Busch C, Lønning PE, Kristensen V, Geisler J.

PLoS One. 2013 Aug 30;8(8):e72692. doi: 10.1371/journal.pone.0072692. eCollection 2013.

39.

Utilization of heme as an iron source by marine Alphaproteobacteria in the Roseobacter clade.

Roe KL, Hogle SL, Barbeau KA.

Appl Environ Microbiol. 2013 Sep;79(18):5753-62. doi: 10.1128/AEM.01562-13. Epub 2013 Jul 19.

40.

Modifications in dynamic contrast-enhanced magnetic resonance imaging parameters after α-particle-emitting ²²⁷Th-trastuzumab therapy of HER2-expressing ovarian cancer xenografts.

Heyerdahl H, Røe K, Brevik EM, Dahle J.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):153-9. doi: 10.1016/j.ijrobp.2013.04.052. Epub 2013 Jun 18.

PMID:
23790511
41.

Effect of a non-calcium-based phosphate binder on fibroblast growth factor 23 in chronic kidney disease.

Spatz C, Roe K, Lehman E, Verma N.

Nephron Clin Pract. 2013;123(1-2):61-6. doi: 10.1159/000351811. Epub 2013 Jun 14.

42.

Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.

Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH.

PLoS One. 2013 May 10;8(5):e63723. doi: 10.1371/journal.pone.0063723. Print 2013.

43.

The use of international service learning initiatives for global health education: case studies from Rwanda and Mexico.

Plumb E, Roe K, Plumb J, Sepe P, Soin K, Ramirez A, Baganizi E, Simmons R, Khubchandani J.

Health Promot Pract. 2013 May;14(3):334-42. doi: 10.1177/1524839913476516. Epub 2013 Mar 4.

PMID:
23460673
44.

Inflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis.

Kumar M, Roe K, Orillo B, Muruve DA, Nerurkar VR, Gale M Jr, Verma S.

J Virol. 2013 Apr;87(7):3655-67. doi: 10.1128/JVI.02667-12. Epub 2013 Jan 9. Erratum in: J Virol. 2018 Jul 17;92(15):.

45.

Analysis of 14,008 uroliths from dogs in the UK over a 10-year period.

Roe K, Pratt A, Lulich J, Osborne C, Syme HM.

J Small Anim Pract. 2012 Nov;53(11):634-40. doi: 10.1111/j.1748-5827.2012.01275.x. Epub 2012 Sep 8.

PMID:
22957984
46.

Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus.

Kumar M, Roe K, Nerurkar PV, Namekar M, Orillo B, Verma S, Nerurkar VR.

PLoS One. 2012;7(8):e44682. doi: 10.1371/journal.pone.0044682. Epub 2012 Aug 31.

47.

Sensitization to bald cypress and cross-reactivity with red cedar in Northeastern Georgia.

Cannington EM, Roe KL, Young PF, Ownby DR.

Ann Allergy Asthma Immunol. 2012 Sep;109(3):220-1. doi: 10.1016/j.anai.2012.06.018. Epub 2012 Jul 17. No abstract available.

PMID:
22920079
48.

Are the Norwegian guidelines for ultrasound in prenatal diagnosis followed?

Røe K, Salvesen KA, Eggebø TM.

Tidsskr Nor Laegeforen. 2012 Aug 7;132(14):1603-7. English, Norwegian.

49.

Hydrogen-limited growth of hyperthermophilic methanogens at deep-sea hydrothermal vents.

Ver Eecke HC, Butterfield DA, Huber JA, Lilley MD, Olson EJ, Roe KK, Evans LJ, Merkel AY, Cantin HV, Holden JF.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13674-9. doi: 10.1073/pnas.1206632109. Epub 2012 Aug 6.

50.

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Røe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, Ree AH, Marignol L, Olsen DR.

Radiat Oncol. 2012 May 23;7:75. doi: 10.1186/1748-717X-7-75.

Supplemental Content

Support Center